Vesugen Lys-Glu-Asp

Vesugen (KED; Lys–Glu–Asp) is described as a tripeptide bioregulator synthesized within Russian bioregulation research with an intended focus on vascular endothelium and gene-level renewal signaling. The protocol’s mechanism section highlights Ki-67 regulation: Vesugen is described as supporting endothelial cell proliferation by modulating expression of Ki-67, a protein closely associated with cell division. The page frames this as potentially involving interaction with promoter regions and epigenetic regulation of gene expression. Additional molecular signals described include normalization of endothelin-1 expression and increased SIRT-1 expression in endothelial cells—findings positioned as supportive of vascular function and resilience. The protocol also notes broader neurobiological findings in the literature it cites, including memory/attention improvements with oral application in older adults and synaptic plasticity effects in Alzheimer’s disease models, though those are presented as experimental. Overall, Vesugen is positioned as an investigational gene-regulatory peptide with generally mild tolerability expectations aside from injection-site reactions.